Hong Ping Yu
Fortuna: 22 M $ al 31/05/2026
Fortuna: 22 M $ al 31/05/2026
Hong Ping Yu is the founder of Abbisko Therapeutics Co., Ltd., founded in 2016, serving as Chief Scientific Officer.
Dr. Yu is the founder of Abbisko Cayman Ltd., founded in 2016, serving as Executive Director & Chief Scientific Officer.
Dr. Yu is currently Director at Abbisko Hong Kong Ltd. since 2018.
Formerly, Dr. Yu was Deputy General Manager at Hansoh Shanghai Pharmaceutical Co. Ltd. from 2011 to 2016.
Education includes a doctorate from the University of British Columbia in 2000, a graduate degree from Tsinghua University in 1994, and an undergraduate degree from Tsinghua University in 1991.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ABBISKO CAYMAN LIMITED 2,43 % | 08/04/2026 | 17.612.962 ( 2,43 % ) | 22 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ABBISKO CAYMAN LIMITED | Fundador | 12/04/2016 |
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology | Fundador | 12/04/2016 |
Abbisko Hong Kong Ltd. | Director/Miembro de la Junta | 01/03/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
Hansoh Shanghai Pharmaceutical Co. Ltd. | Corporate Officer/Principal | 01/01/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology | Health Technology |
Abbisko Cayman Ltd.
Abbisko Cayman Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to the discovery and development of small molecule oncology therapies | Health Technology |
Abbisko Hong Kong Ltd. | |
Hansoh Shanghai Pharmaceutical Co. Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.